Cinctive Capital Management’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-978
| Closed | -$18K | – | 539 |
|
2022
Q2 | $18K | Sell |
978
-6,068
| -86% | -$112K | ﹤0.01% | 437 |
|
2022
Q1 | $210K | Hold |
7,046
| – | – | 0.01% | 387 |
|
2021
Q4 | $306K | Sell |
7,046
-2,932
| -29% | -$127K | 0.01% | 440 |
|
2021
Q3 | $710K | Buy |
9,978
+1,978
| +25% | +$141K | 0.03% | 403 |
|
2021
Q2 | $918K | Buy |
+8,000
| New | +$918K | 0.04% | 361 |
|